• About us
• Contact

Advertisement

Organisation › Details

Oribiotech Ltd. (d/b/a Ori Biotech)

Ori is a London-and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies. Ori has developed a proprietary, full stack manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics. Ori was founded in 2015 by Dr. Farlan Veraitch (UCL) and has brought together a seasoned Board and management team with over 200 years of combined pharmaceutical, CGT and venture building experience including CEO Jason C. Foster (Indivior), CBO Jason Jones (Miltenyi), CDOO Kevin Gordon (Tmunity), CTO Stuart Milne (Cytiva), VP Tom Heathman (Minaris), VP David Smith (Minaris), VP Lee Unroe (Indivior), Chris Mason (AVROBIO), Paul Meister (ThermoFisher) and Annalisa Jenkins (Dimension Therapeutics) alongside expert advisers like Bruce Levine, Anthony Davies, and Robert Preti. *

 

	Start	2015-09-02 established
	Group	Ori Biotech (Oribiotech) (Group)
	Industry	cell therapy manufacturing/processing technology
	Industry 2	gene therapy manufacturing/processing technology
	Person	Foster, Jason C. (Oribiotech 202001– CEO)
	Person 2	Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder)
	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	35 Beaufort Court Admirals Way South Quay Waterside
	City	E14 9XL London
		Address record changed: 2024-01-05
Basic data	Employees	n. a.
		* Document for »About Section«: Ori Biotech Ltd.. (1/18/22). "Press Release: Ori Biotech Raises over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform". London.
		Record changed: 2023-07-10

Advertisement

More documents for Ori Biotech (Oribiotech) (Group)

• [1] Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC....
• [2] Ori Biotech Ltd.. (9/13/22). "Press Release: Ori Biotech and CTMC Partner to Accelerate Novel Cell Therapy Delivery". London & Houston, TX....
• [3] Ori Biotech Ltd.. (8/30/22). "Press Release: Ori Biotech Adds to Senior Team, Scientific Advisory Board and Expands Global Footprint". London....
• [4] Ori Biotech Ltd.. (1/18/22). "Press Release: Ori Biotech Raises over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform". London....
• [5] Ori Biotech Ltd.. (8/25/21). "Press Release: Ori Biotech Expands Board of Directors and Scientific Advisory Board". London....
• [6] Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ....
• [7] Ori Biotech Ltd.. (12/15/20). "Press Release: Ori Biotech Adds to Its World-Class Team". London & Woodcliff Lake, NJ....
• [8] Ori Biotech Ltd.. (10/14/20). "Press Release: Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Woodcliff Lake, NJ....
• [9] Ori Biotech Ltd.. (7/28/20). "Press Release: Ori Biotech Appoints Thomas Heathman, PhD to Lead Commercial Operations in North America". Philadeliphia, PA & London....
• [10] Ori Biotech Ltd.. (1/8/20). "Press Release: Ori Biotech Announces a $9.4m Seed Round to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Philadelphia, PA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.